Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Dzevka Dragic"'
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background DNA methylation is a potential biomarker for early detection of breast cancer. However, robust evidence of a prospective relationship between DNA methylation patterns and breast cancer risk is still lacking. The objective of this
Externí odkaz:
https://doaj.org/article/c0e1e06975974c20b558075ddbc2b803
Autor:
Dzevka Dragic, Sue-Ling Chang, Kaoutar Ennour-Idrissi, Francine Durocher, Gianluca Severi, Caroline Diorio
Publikováno v:
Epigenomics. 14:793-810
Aim: We systematically reviewed and evaluated current literature on alcohol consumption and DNA methylation (DNAm) at the genome-wide and probe-wise level in blood of adults. Materials & methods: Five databases (PubMed, Embase, Web of Science, CINAHL
Autor:
Daniela Furrer, Dzevka Dragic, Sue-Ling Chang, Frédéric Fournier, Arnaud Droit, Simon Jacob, Caroline Diorio
Publikováno v:
Cancer Drug Resistance. 5:995-1015
Recent evidence suggests that genetic and epigenetic mechanisms might be associated with acquired resistance to cancer therapies. The aim of this study was to assess the association of genome-wide genetic and epigenetic alterations with the response
Autor:
Alessandra Allione, Clara Viberti, Ilaria Cotellessa, Chiara Catalano, Elisabetta Casalone, Giovanni Cugliari, Alessia Russo, Simonetta Guarrera, Dario Mirabelli, Carlotta Sacerdote, Marco Gentile, Fabian Eichelmann, Matthias B. Schulze, Sophia Harlid, Anne Kirstine Eriksen, Anne Tjønneland, Martin Andersson, Martijn E.T. Dollé, Heleen Van Puyvelde, Elisabete Weiderpass, Miguel Rodriguez‐Barranco, Antonio Agudo, Alicia K. Heath, María‐Dolores Chirlaque, Thérèse Truong, Dzevka Dragic, Gianluca Severi, Sabina Sieri, Torkjel M. Sandanger, Eva Ardanaz, Paolo Vineis, Giuseppe Matullo
Malignant pleural mesothelioma (MPM) is a rare and aggressive cancer mainly caused by asbestos exposure. Specific and sensitive non-invasive biomarkers may facilitate and enhance screening programs for the early detection of cancer. We investigated D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fecea85750090c165312cc387b6635a3
https://hdl.handle.net/10037/28766
https://hdl.handle.net/10037/28766
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
BMC Cancer
BMC Cancer
Background DNA methylation is a potential biomarker for early detection of breast cancer. However, robust evidence of a prospective relationship between DNA methylation patterns and breast cancer risk is still lacking. The objective of this study is
Autor:
Sue-Ling Chang, Caroline Diorio, Elissar Issa, Francine Durocher, Annick Michaud, Louise Provencher, Kaoutar Ennour-Idrissi, Dzevka Dragic
Publikováno v:
Cancers, Vol 12, Iss 3088, p 3088 (2020)
Cancers
Volume 12
Issue 11
Cancers
Volume 12
Issue 11
Differential DNA methylation is a potential marker of breast cancer risk. Few studies have investigated DNA methylation changes in normal breast tissue and were largely confounded by cancer field effects. To detect methylation changes in normal breas
Autor:
Annick Michaud, Francine Durocher, Dzevka Dragic, Kaoutar Ennour-Idrissi, Caroline Diorio, Sue-Ling Chang
Publikováno v:
Anticancer research. 40(4)
Background/aim Several studies have investigated the influence of obesity on DNA methylation (DNAm) to find biomarkers associated with the detection of chronic diseases, including breast cancer. The aim of the study was to systematically review studi
Additional file 1 : Table S1. Search strategy for Medline via PubMed. Table S2. Studies of blood-derived methylation and breast cancer risk. Table S3. Studies of breast tissue methylation and breast cancer risk.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13791576feffa7c6356183f9d5217126
Publikováno v:
The FASEB Journal. 33